New Effective Targets
Sunil Verma, MD, MSEd, FRCPC
Video Categories: ESMO 2016
Sunil Verma, MD, MSEd, FRCPC discusses new classes of therapies for HR+ Breast Cancer.
Dr. Jorge Cortes provides examples of how personalized or precision medicine has positively impacted the approach to cancer care, citing the benefits of FLT3 inhibitors, IDH inhibitors, and MEK inhibitors, and other targeted treatments.
John Hennessy provides a few benefits of personalized medicine as it effects the ability to make better treatment choices earlier rather than later